In 2025, Colombia’s regulated export market is less about “can you ship?” and more about “can you prove every step of the shipment’s legal origin, quality controls, and custody—down to the lot and the seal number?” The compliance bar is being raised by tighter coordination between the VUCE single-window process, the multiple “visto bueno” (prior authorization) authorities, and the documentation expectations set out in Resolución Conjunta 539 de 2022 (commonly referenced in industry as “Resolution 539”), which operationalizes parts of Decreto 811 de 2021.
For exporters and foreign buyers, the practical takeaway is straightforward: customs clearance and seizure risk increasingly hinge on whether your paperwork and traceability records match across systems—VUCE filings, commercial documents, lab reports, quotas/authorizations, and transport security logs.
This article is informational only and not legal advice.
Why Resolution 539 matters more in 2025 than it did in 2022
Decreto 811 de 2021 updated Colombia’s framework for regulated medical/scientific and industrial activities and opened important pathways for international trade. But the decree left a real-world gap: exporters and importers needed a detailed, inter-agency playbook for cross-border movements of seeds, plant material, derivatives, and finished products.
Resolución Conjunta 539 de 2022 filled that operational gap by:
- Defining how import/export requests must be presented through VUCE and when authorities must issue their respective vistos buenos.
- Clarifying which entities participate depending on the type of material and the direction of the transaction (import vs export, national customs territory vs free trade zone).
- Reinforcing the principle that the same shipment must be “coherent” across licenses, quotas/authorizations, quality documentation, and logistics custody records.
Official references:
The regulator map for exports: who signs off, and why that changes by product
A common source of delays is assuming one authority’s approval is enough. Under the Resolution 539 trade scheme, the approvals are split by product category and the type of control exercised.
Practical compliance insight
In 2025, exporters that perform best operationally tend to treat approvals as a single “release package,” not separate tasks. That means:
- The same lot identifiers appear in: manufacturing batch records, COAs, packing lists, invoices, VUCE item lines, and transport seals.
- The same consignee/importer identity (legal name, address, authorization/license number) is consistent across: destination import permit, pro forma/commercial invoice, airway bill/bill of lading, and any FNE certificate.
Documentation package: what “complete” looks like for 2025–2026 shipments
Resolution 539 formalized the trade authorization path, but most seizures and holds happen for a simpler reason: documentation mismatch. Below is a practical “documentation stack” you can build for each shipment.
1) Licensing and authorization foundation
Before you assemble shipment documents, confirm the legal ability to produce and export the specific material.
Include (as applicable):
- Applicable Colombian licenses for the activity and material (cultivation/manufacturing/seed activities).
- Company identification (RUT/NIT details) matching what will be used on invoices and DIAN/VUCE filings.
- Export plan alignment: if your internal plan/authorizations specify annual export projections, keep evidence that this shipment fits within the planned scope.
Why this matters: authorities reviewing vistos buenos will often compare your request against what your license scope and controls allow.
2) Destination-country import authorization (the “anchor” document)
For regulated international trade in controlled substances, the most critical document is usually the importer’s authorization.
Best practice is to obtain:
- Official import permit / import authorization issued by the destination country’s competent authority.
- A translation (where needed) plus a notarized or certified copy if local practice requires.
International context: the INCB describes the treaty-based requirement that exporting countries require an import authorization/certificate before issuing export authorizations. See INCB’s trade controls overview: https://i2es.incb.org/Documents/Controls%20On%20International%20Trade.pdf
3) Product classification & “what is it?” dossier (API vs finished product matters)
One of the most common friction points in cross-border compliance is classification ambiguity—especially when the destination market distinguishes between active pharmaceutical ingredient (API), intermediate, and finished dosage form.
Build a short dossier that includes:
- Product description (form, concentration, intended use, and whether it is crude extract, purified extract, isolate, API, or finished dosage form).
- HS code / subpartida arancelaria used in VUCE/DIAN filings.
- Specification sheet (quality attributes, accepted limits, and methods).
- Stability statement or storage conditions supporting the chosen shelf-life and shipping temperature.
For shipments to the EU (or EU-aligned regimes), buyers will usually insist on:
- Evidence of manufacturing under an acceptable GMP standard for the product type.
- A clear plan for import testing and Qualified Person (QP) release responsibilities when applicable.
Note: EU GMP expectations differ depending on whether the material is API (EU GMP Part II) or a finished medicinal product (EU GMP Part I), and importation into the EU triggers specific obligations for import authorization holders and QP certification. A plain-language overview is discussed here (industry compliance resource): https://www.qbdgroup.com/en/blog/importing-medicinal-products-into-eu-brief-guide-to-eu-gmp-compliance/
4) Lot-level testing and Certificate of Analysis (COA)
Colombian exporters increasingly need “export-grade” testing packages, even when not explicitly required by Colombia for every destination.
At a minimum, align COAs to:
- Lot/batch identifiers that match packaging and logistics records.
- Method references (validated methods preferred).
- Sampling plan and sampling chain-of-custody.
- Accreditation details for the lab, where relevant.
If you use accredited labs, keep proof of accreditation scope. ONAC’s accreditation information and lab program: https://onac.org.co/servicios/laboratorios-de-ensayo/
Destination-country alignment tip:
- EU buyers commonly require microbiological limits, residual solvents (for extracts), heavy metals, pesticides, and mycotoxins aligned with their monographs/specifications.
- Some destinations will require stability, photostability, and packaging compatibility evidence.
5) Traceability and chain-of-custody records (the “seizure prevention” layer)
Resolution 539’s compliance philosophy—paired with broader international controlled-trade norms—pushes exporters to maintain a defensible chain of custody.
A strong chain-of-custody pack typically includes:
- Master batch record and executed batch record (manufacturing steps, yields, deviations).
- Lot genealogy: how the exported lot relates to input materials (including internal lots) and storage locations.
- Inventory movement logs showing transfers into quarantine, sampling, release, packing, and dispatch.
- QA release decision (release certificate signed by QA/QC).
- Packaging and labeling reconciliation (counts in/out, destruction of rejects).
- Tamper-evident seal log: seal numbers, who applied, when, and verification at handovers.
Why it matters in 2025: if customs or enforcement challenges the shipment, you need to prove it is the same, unchanged lot from release to export, with controlled access throughout.
6) Commercial documents that must match the regulatory file
Even where the regulatory approvals are correct, commercial document mismatch is a frequent cause of holds.
Ensure consistency across:
- Pro forma invoice (often used early with the importer for permits)
- Commercial invoice (final)
- Packing list
- Transport document (AWB/BL)
- Insurance certificate (if required)
Details that often trigger a hold:
- Different company names or addresses for exporter/importer between invoice and import permit
- Units (grams vs kilograms) inconsistent across COA, invoice, and packing list
- Net weight mismatch between packing list and airway bill
- Missing lot numbers on packing list while present on COA
Quotas and approvals: how volume controls connect to shipment paperwork
Many exporters focus on “getting the permit,” but overlook how volume controls appear across the document stack.
Practical 2025 approach:
- Treat your quota/cupo (where applicable) and your export certificate/authorization as constraints that must be reflected in the invoice quantities and DIAN declaration.
- Maintain an internal quota ledger that shows: opening balance, shipments deducted, adjustments, and remaining availability.
Colombia’s FNE publishes periodic reporting on regulated activities and includes discussion of controlled categories (example July 2025 report PDF): https://fne.minsalud.gov.co/sustancias-fiscalizadas/Informes/INFORME%20CANNABIS%20julio%202025%20publicar.pdf
Transport security & customs clearance: turning paperwork into a defensible shipment
Resolution 539 is not only “forms and permits”—it effectively expects exporters to operate like a controlled-pharma supply chain.
Security controls that support chain-of-custody
Include or implement:
- Secure staging (restricted-access packing area, visitor logs)
- Two-person verification for picking and packing high-risk shipments
- Seal application SOP and photo evidence of sealed pallets/containers
- Carrier due diligence: contract clauses for secure handling and incident reporting
- Temperature monitoring (if required) and data logger download stored with batch file
Customs coherence checklist (Colombia side)
Before cargo handoff, verify:
- VUCE visto bueno approvals are issued and valid for the specific shipment details.
- DIAN export documents reflect the same product description, HS codes, and quantities.
- All attachments (COA, invoices, permits) are in final form and match.
DIAN’s export basics overview is a useful refresher for exporters aligning the operational sequence: https://www.dian.gov.co/aduanas/Regimen-de-Aduanas/Documents/ABC-Aspectos-basicos-Exportacion.pdf
Destination-country alignment: designing your export file for EU‑GMP buyers and other strict markets
Foreign buyers—especially in Europe—often impose requirements beyond Colombian export authorizations.
EU‑GMP alignment (common buyer expectations)
Even when your shipment is not a finished medicinal product, EU buyers commonly want:
- A documented quality management system (QMS)
- Supplier qualification records
- Deviation/CAPA history summary
- Change control overview
- Traceability from source lots to exported lots
If you ship a finished dosage form intended for an EU market pathway, expect heavy emphasis on:
- Batch release strategy involving an EU importer and QP
- Import testing strategy and sample retention
A practical overview of EU import/QP expectations: https://www.qbdgroup.com/en/blog/importing-medicinal-products-into-eu-brief-guide-to-eu-gmp-compliance/
Brazil (individual patient import channel) as an example of “document translation risk”
Brazil’s Anvisa has an established process for exceptional import by individuals under RDC 660/2022. When a Colombian exporter supplies into a channel connected to individual authorizations, paperwork must match that model.
Official Anvisa service page referencing RDC 660/2022: https://www.gov.br/pt-br/servicos/solicitar-autorizacao-para-importacao-excepcional-de-produtos-a-base-de-canabidiol
Colombia’s FNE issued additional export-tramite guidance in early 2026 (relevant for 2025–2026 planning) via Circular Externa 001-2026 (PDF): https://fne.minsalud.gov.co/Style%20Library/assets/Fne_paginas/Home/Banner/22012026/CIRCULAR%20EXTERNA%20001-2026.pdf
A pre‑export audit template (2025–2026) for Colombian licensees and foreign buyers
Use the following template as a “go/no-go” internal audit before any international shipment. It is designed to reduce seizure risk and accelerate clearance.
Step 1 — Counterparty and authorization validation
- Confirm the importer’s legal name, address, and license number.
- Obtain the destination import authorization and confirm it covers:
- product form
- concentration (if applicable)
- quantity
- shipment window/validity dates
- Confirm consignee matches the transport document consignee.
Step 2 — Product identity and classification lock
- Freeze the final product description.
- Confirm HS code/subpartida aligns with past filings and destination classification.
- Confirm whether the product is treated as API, intermediate, or finished product in the destination regime.
- Confirm packaging configuration (unit size, number of units, net/gross weight).
Step 3 — Quality and testing readiness (lot-level)
- Confirm executed batch record is complete and reviewed.
- Confirm COA is final and includes:
- batch/lot number
- test methods and results
- lab identification and (where applicable) accreditation statement
- Confirm sample retention plan and retains are stored.
Step 4 — Traceability and custody evidence pack
- Confirm inventory movements show an unbroken path from release to dispatch.
- Confirm packing reconciliation is complete.
- Confirm seal log is created with:
- seal numbers
- application time/date
- responsible persons
- verification at handover
Step 5 — Regulatory approvals and system coherence
- Confirm all required vistos buenos are approved in VUCE for the exact shipment details.
- Confirm any FNE export certificate/concept is issued where required for the product category.
- Confirm any ICA phytosanitary certificate requirements are satisfied for plant-origin shipments.
Key systems to reference:
Step 6 — Commercial and customs document reconciliation
- Confirm pro forma and commercial invoice match the permit quantities and units.
- Confirm packing list includes lot numbers and net/gross weights.
- Confirm AWB/BL reflects correct consignee and package counts.
- Confirm DIAN export filing data matches invoices and VUCE.
Step 7 — Logistics and security controls
- Confirm carrier booking and secure route.
- Confirm temperature controls (if needed) and logger placement.
- Confirm incident response plan and contacts.
Enforcement reality: what gets shipments stopped in 2025
Even with valid authorizations, enforcement actions and delays frequently arise from:
- Document inconsistency (names, addresses, quantities, units, dates)
- Lot traceability gaps (COA lot doesn’t match packing list; missing chain-of-custody signatures)
- Misclassification (API vs finished product confusion, mismatched HS/subpartida)
- Weak transport security (no seal log, no handover evidence)
Resolution 539’s main contribution is that it provides the inter-agency “logic” for what reviewers expect to see. In practice, your goal is to make the shipment file so coherent that an auditor can reconstruct the transaction without assumptions.
Key takeaways for exporters and foreign buyers
- Resolution 539 (Conjunta 539 de 2022) is the operational backbone for Colombia’s international trade approvals under the post‑Decreto 811 framework.
- The winning strategy in 2025–2026 is lot-level coherence: every identifier and quantity must match across permits, COAs, invoices, packing lists, VUCE lines, and transport documents.
- Treat chain-of-custody as a shipment deliverable, not an internal note—because it is increasingly what prevents seizures.
- Buyers should conduct a pre‑export audit on the Colombian exporter’s documentation package before cargo is tendered to the carrier.
Next step: turn this into a repeatable compliance workflow
If you’re building or scaling exports, the fastest way to reduce holds is to standardize a per-shipment “export dossier” and run the pre‑export audit every time.
Use https://cannabisregulations.ai/ to track regulatory changes, build document checklists by jurisdiction, and operationalize cannabis compliance workflows for licensing, quality, and international shipment readiness.
